These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11687316)

  • 1. Validation of the VITEK2 and the Advance Expert System with a collection of Enterobacteriaceae harboring extended spectrum or inhibitor resistant beta-lactamases.
    Cantón R; Pérez-Vázquez M; Oliver A; Coque TM; Loza E; Ponz F; Baquero F
    Diagn Microbiol Infect Dis; 2001; 41(1-2):65-70. PubMed ID: 11687316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactams.
    Pottumarthy S; Yu Y; Sader HS; Jones RN; Chen M
    Diagn Microbiol Infect Dis; 2005 Oct; 53(2):131-41. PubMed ID: 15939566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
    Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality control for beta-lactam susceptibility testing with a well-defined collection of Enterobacteriaceae and Pseudomonas aeruginosa strains in Spain.
    Cantón R; Loza E; Del Carmen Conejo M; Baquero F; Martínez-Martínez L;
    J Clin Microbiol; 2003 May; 41(5):1912-8. PubMed ID: 12734226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].
    Philippon A; Jarlier V; Legrand P; Fournier G; Nicolas MH; Duval J
    Presse Med; 1989 Oct; 18(32):1560-6. PubMed ID: 2530532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.
    Jarlier V; Nicolas MH; Fournier G; Philippon A
    Rev Infect Dis; 1988; 10(4):867-78. PubMed ID: 3263690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of extended-spectrum beta-lactamases production in enterobacteriaceae strains].
    Tuchiluş C; Poiată A; Bosnea D; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(1):137-41. PubMed ID: 12092141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline.
    Morosini MI; García-Castillo M; Coque TM; Valverde A; Novais A; Loza E; Baquero F; Cantón R
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2695-9. PubMed ID: 16870760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
    Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
    Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid-Mediated AmpC β-Lactamase and Underestimation of Extended-Spectrum β-Lactamase in Cefepime-Susceptible Elevated-Ceftazidime-MIC Enterobacteriaceae Isolates.
    Nishimura F; Morinaga Y; Akamatsu N; Matsuda J; Kaku N; Takeda K; Uno N; Kosai K; Hasegawa H; Yanagihara K
    Jpn J Infect Dis; 2018 Jul; 71(4):281-285. PubMed ID: 29709981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of extended-spectrum beta-lactamases and its correlation with clinical laboratory standards institute interpretive criteria for disk diffusion susceptibility testing in enterobacteriaceae isolates in Thaialnd.
    Tangkoskul T; Tiengrim S; Onsomang S; Pati N; Aswapokee N; Thamlikitkul V; Chayakulkeeree M
    Southeast Asian J Trop Med Public Health; 2012 Nov; 43(6):1461-9. PubMed ID: 23413710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligonucleotide microarrays with horseradish peroxidase-based detection for the identification of extended-spectrum β-lactamases.
    Rubtsova MY; Ulyashova MM; Edelstein MV; Egorov AM
    Biosens Bioelectron; 2010 Dec; 26(4):1252-60. PubMed ID: 20643540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bulgarian hospitals.
    Markovska R; Schneider I; Keuleyan E; Sredkova M; Ivanova D; Markova B; Lazarova G; Dragijeva E; Savov E; Haydouchka I; Hadjieva N; Setchanova L; Mitov I; Bauernfeind A
    Microb Drug Resist; 2008 Jun; 14(2):119-28. PubMed ID: 18489242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a phenotypic screening strategy for emerging β-lactamases in Gram-negative bacilli.
    Willems E; Verhaegen J; Magerman K; Nys S; Cartuyvels R
    Int J Antimicrob Agents; 2013 Feb; 41(2):99-109. PubMed ID: 23280443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of TEM-52/TEM-92 and SHV-12 extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae in Italy.
    Perilli M; Segatore B; Mugnaioli C; Celenza G; Rossolini GM; Stefani S; Luzzaro F; Pini B; Amicosante G
    Microb Drug Resist; 2011 Dec; 17(4):521-4. PubMed ID: 21970626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex beta-lactamase patterns including extended-spectrum enzymes.
    Segatore B; Setacci D; Perilli M; Franchino L; Franceschini N; Agnifili A; Rossolini GM; Amicosante G
    Int J Antimicrob Agents; 2004 May; 23(5):480-6. PubMed ID: 15120727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.